Company / Interest Expense per Share
Larimar Therapeutics, Inc. Interest Expense per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2019
5-year range
$0.00 / $0.04
FY2015-FY2019
Trend
-77.0%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has declined for 5 consecutive years, from $0.13 in FY2014 to $0.00 in FY2019.
Based on SEC 10-K filings.
0.00 in FY2019 with a 5-year CAGR of -49.4%.
Improved from $0.03 to $0.00 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -48.3%
- 5-Year CAGR
- -49.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Larimar Therapeutics, Inc.'s interest expense per share has declined for 5 consecutive years.
- In FY2019, interest expense per share decreased 77.0% year-over-year.
- Peak interest expense per share was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.00 | -77.0% |
| FY2018 | $0.02 | -34.7% |
| FY2017 | $0.03 | -7.7% |
| FY2016 | $0.03 | -16.0% |
| FY2015 | $0.04 | -71.4% |
| FY2014 | $0.13 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026